Holen Sie sich die Stockscreener-App
6.72
1.18%
-0.08
Handel nachbörslich:
6.77
0.05
+0.74%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.80
Offen:
$6.9
24-Stunden-Volumen:
2.29M
Relative Volume:
0.93
Marktkapitalisierung:
$1.85B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
-35.37
EPS:
-0.19
Netto-Cashflow:
$18.24M
1W Leistung:
-6.93%
1M Leistung:
+1.82%
6M Leistung:
+46.41%
1J Leistung:
+76.84%
1-Tages-Spanne:
$6.68
$6.9343
1-Wochen-Bereich:
$6.62
$7.44
52-Wochen-Spanne:
$3.17
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Firmenname
Mannkind Corp
Sektor
Branche
Telefon
818-661-5000
Adresse
1 CASPER STREET, DANBURY, CA
Vergleichen Sie MNKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MNKD | 6.72 | 1.85B | 248.37M | 11.74M | 18.24M | -0.19 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-10 | Eingeleitet | Wedbush | Outperform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-10-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2018-02-28 | Herabstufung | Maxim Group | Hold → Sell |
| 2017-11-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-10-06 | Bestätigt | Maxim Group | Buy |
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-05-10 | Bestätigt | Piper Jaffray | Underweight |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Underperform |
| 2016-01-06 | Bestätigt | Piper Jaffray | Underweight |
| 2016-01-06 | Bestätigt | RBC Capital Mkts | Underperform |
| 2015-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-05-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Bestätigt | MLV & Co | Hold |
| 2015-04-16 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
Insulin Pump Market Report 2024-2035, Featuring Profiles of Leading Players Including Beta Bionics, CeQur, EOFlow, Insulet, LA Roche, MannKind, Medtronic, Medtrum Technologies and MicroPort - Yahoo Finance
MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript - Insider Monkey
MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Insider Sale: Chief People & Workpl Officer Stuart Tross Sells 5 - GuruFocus.com
MannKind Corp's chief people officer Stuart Tross sells $403,700 in stock - Investing.com Australia
Earnings call: MannKind sees growth and pipeline progress in Q3 2024 - Investing.com
MannKind Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Quantisnow
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Re - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
MannKind (MNKD) Q3 2024 Earnings Call Transcript - Yahoo! Voices
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
MannKind Corp Q3 2024 Earnings: EPS of $0.04 Beats Estimates, Re - GuruFocus.com
MannKind (MNKD) Matches Q3 Earnings Estimates - Yahoo Finance
MannKind: Q3 Earnings Snapshot - Thehour.com
MannKind stock soars to 52-week high, hits $7.38 - Investing.com
MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Lo - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
International Assets Investment Management LLC Raises Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Reaches New 1-Year HighWhat's Next? - MarketBeat
MannKind Stock Surge Pre-Market Fueled by Promising Nintedanib DPI Trial Results, Driving Retail Optimism - Barchart
Creative Planning Reduces Position in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - ForexTV.com
MannKind (NASDAQ:MNKD) Sets New 1-Year HighTime to Buy? - MarketBeat
MannKind stock soars to 52-week high, touches $6.93 - Investing.com
MannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results - AOL
SG Americas Securities LLC Takes Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Mannkind Corp (MNKD) receives an Outperform rating from Leerink Partners - Knox Daily
Recent Insider Activity Could Benefit 3M Co. (MMM) - Knox Daily
Holdings of Mannkind Corp (MNKD) are aligned with the stars - SETE News
Selling Buzz: Mannkind Corp [MNKD] Chief People & Workpl Officer Tross Stuart A sells 25,000 shares of the company - Knox Daily
Ratios Revealed: Decoding Mannkind Corp (MNKD)’s Financial Health - The Dwinnex
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... By GuruFocus - Investing.com Canada
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... - Yahoo Finance
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Re - GuruFocus.com
Did Mannkind Corp (MNKD) perform well in the last session? - US Post News
Potential Price Increase for Mannkind Corp (MNKD) After Recent Insider Activity - Knox Daily
Mannkind Corp (MNKD) can make a big difference with a little luck - SETE News
Squarepoint Ops LLC Sells 133,926 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Why MannKind (MNKD) Could Beat Earnings Estimates Again - Yahoo Finance
MannKind (MNKD) Just Overtook the 20-Day Moving Average - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Purchased by Millennium Management LLC - MarketBeat
MannKind (NASDAQ:MNKD) Shares Up 3.2% - MarketBeat
MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion - Seeking Alpha
Marshall Wace LLP Sells 205,764 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
A better buy-in window may exist right now for Mannkind Corp (MNKD) - SETE News
MannKind's SWOT analysis: inhaled therapeutics firm's stock shows promise amid challenges - Investing.com
More Adults With Type 1 Diabetes Achieved A1C Goal ( - Yahoo Finance
Finanzdaten der Mannkind Corp-Aktie (MNKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):